Interventional Study to Improve Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL PositiveMedication Adherence
Interventions
BEHAVIORAL

Adherence-encouraging interventions - Group meeting

One Group meeting (at the beginning of the intervention period) for all participants, focusing on issues relevant to adherence improvement

BEHAVIORAL

Adherence-encouraging interventions - Individual meetings

Individual meetings focusing on adherence issues with a multidiscilinary team

BEHAVIORAL

Adherence-encouraging interventions - Monthly phone calls

Monthly phone calls to detect urgent adherence-related issues

Trial Locations (4)

44281

Meir Medical Center, Kfar Saba

49100

Rabin Medical Center, Petah Tikva

84101

Soroka Medical Center, Beersheba

Unknown

Rambam Medical Center, Haifa

All Listed Sponsors
lead

pia raanani

OTHER

NCT01768689 - Interventional Study to Improve Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia | Biotech Hunter | Biotech Hunter